Closed
Save

High-Resolution Mass Spectrometry System with Ultra-High-Performance Liquid Chromatography

Health & Human Services (HHS) > FDA > FDA OFFICE OF ACQ GRANT SVCSSol: 75F40126Q00088
est. $150K – $500K

This opportunity is closed

The response deadline has passed. Review the details for future reference or to track similar opportunities.

Quick Brief

The Department of Health and Human Services intends to procure an Orbitrap Excedion Pro BioPharma Mass Spectrometer and UHPLC system to support pharmaceutical analysis, including impurity characterization. The system must meet specific technical requirements for high-resolution mass detection and be compatible with regulatory-grade workflows.

Generated 33d ago

Scope & Requirements

The work involves the delivery and installation of a high-resolution mass spectrometry system with ultra-high-performance liquid chromatography capabilities, along with training and support services.

Deliverables

  • High-resolution accurate-mass mass spectrometry system
  • Integrated ultra-high-performance liquid chromatography system
  • Instrument control and data analysis software
  • Delivery, installation, and instrument qualification services
  • Vendor-provided operational training
  • Minimum one-year manufacturer warranty

Contract Details

Estimated Value
est. $150K – $500K
Similar contracts award $14K$90K (median $32K, 27,674 awards)Above typical range
NAICS Codes

Qualifications & Eligibility

Set-Aside Category
FAR 19.5

Agency & Contact

Contracting Organization

Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-Agency
FOOD AND DRUG ADMINISTRATION
Office
FDA OFFICE OF ACQ GRANT SVCS

Point of Contact

John A. Smith
Contracting Officer
(202) 555-0100

Key Dates

Published1mo ago
May 1, 2026
Last Updated1mo ago
May 1, 2026
Became Solicitation1mo ago
May 1, 2026
Tracked
Response Due17d ago
May 18, 2026

Description

The Government intends to acquire a high-resolution mass spectrometry system with ultra-high-performance liquid chromatography capability to support the analysis of pharmaceutical drug substances and drug products, including detection and characterization of nitrosamine impurities, small molecules, peptides, and other biomolecules.

The Thermo Scientific Orbitrap Excedion Pro BioPharma MS and UHPLC system is referenced as the brand-name product used to define the level of performance and functionality required.

This acquisition is conducted on a brand-name-or-equal basis.

Products offered as an “equal” must meet or exceed the salient characteristics identified below in order to be considered technically acceptable.

The Government requires an integrated LC-MS analytical system capable of supporting regulatory-grade analytical workflows for pharmaceutical quality evaluation and impurity characterization.

The system must provide high-resolution, accurate-mass detection across a wide mass range to support both small molecule and biomolecule applications, including trace-level impurity detection and characterization of peptide-based therapeutics.

Get matched to contracts like this daily

Free AI-powered contract matching for your business.